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Fibroblast growth factor 8 (FGF8) is a potent morphogen that regulates the embryonic
development of hypothalamic neuroendocrine cells. Indeed, using Fgf8 hypomorphic
mice, we showed that reduced Fgf8 mRNA expression completely eliminated the
presence of gonadotropin-releasing hormone (GnRH) neurons. These findings suggest
that FGF8 signaling is required during the embryonic development of mouse GnRH
neurons. Additionally, in situ hybridization studies showed that the embryonic primordial
birth place of GnRH neurons, the olfactory placode, is highly enriched for Fgf8 mRNA
expression. Taken together these data underscore the importance of FGF8 signaling
for GnRH emergence. However, an important question remains unanswered: How is
Fgf8 gene expression regulated in the developing embryonic mouse brain? One major
candidate is the androgen receptor (AR), which has been shown to upregulate Fgf8
mRNA in 60–70% of newly diagnosed prostate cancers. Therefore, we hypothesized
that ARs may be involved in the regulation of Fgf8 transcription in the developing mouse
brain. To test this hypothesis, we used chromatin-immunoprecipitation (ChIP) assays to
elucidate whether ARs interact with the 5′UTR region upstream of the translational start
site of the Fgf8 gene in immortalized mouse GnRH neurons (GT1-7) and nasal explants.
Our data showed that while AR interacts with the Fgf8 promoter region, this interaction
was androgen-independent, and that androgen treatment did not affect Fgf8 mRNA
levels, indicating that androgen signaling does not induce Fgf8 transcription. In contrast,
inhibition of DNA methyltransferases (DNMT) significantly upregulated Fgf8 mRNA levels
indicating that Fgf8 transcriptional activity may be dependent on DNAmethylation status.
Keywords: Fgf8, GnRH neurons, androgen receptor (AR), olfactory placode, DNA methyltransferases, 5-
azacytidine
INTRODUCTION
Traditionally, fibroblast growth factor 8 (FGF8) has been studied in the context of a potent
morphogen that is required for establishing morphogenetic centers in the developing mammalian
neural tube (Crossley and Martin, 1995; Meyers et al., 1998; Sun et al., 1999). Indeed, Fgf8
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mRNA and protein is highly expressed in the early embryonic
midbrain-hindbrain border, and the anterior neural ridge
(Crossley and Martin, 1995; Kawauchi et al., 2004). Recently, we
showed that FGF8 function is also important for the development
of gonadotropin-releasing hormone (GnRH)-secreting
neurons, which reside within the preoptic-hypothalamus
region. Specifically, while GnRH neurons were present in
newborn wildtype Fgf8 hypomorphic mice, they were absent in
homozygous litter mates (Chung et al., 2008). Additional studies
showed that GnRH neurons were already missing in the E11.5
Fgf8 hypomorphic olfactory placode (OP) (Wray et al., 1989;
Chung et al., 2008) from which the majority of GnRH neurons
emerge (Schwanzel-Fukuda and Pfaff, 1989; Wray et al., 1989).
Together these data clearly support the supposition that FGF8
function is required for vertebrate GnRH neuron development
(Chung et al., 2008; Tsai et al., 2011).
In vitro explant studies in chicken OP explants further
pinpointed that FGF8 function is required for the emergence
of GnRH neurons. Normally, GnRH precursor cells in the
chicken OP are specified around the Hamburger and Hamilton
(HH) stage 16/17. Treatment of HH15 OP with FGF8 advanced
the emergence of GnRH neurons by ∼24 h (Sabado et al.,
2012), which was abrogated by a FGF antagonist in HH17 OP
(Sabado et al., 2012). These studies not only support the general
supposition that FGF8 function is required for fate-specifying
GnRH precursor cells, but also that FGF8 only has a narrow
window of opportunity to induce the emergence of GnRH
neurons.
Although, much is already known about the effects of FGF8
function on GnRH neuron development, it is unclear how
Fgf8 transcription is controlled in the mammalian OP. Data
from breast and prostatic cancer cell studies indicate that Fgf8
transcription is, in part, under the regulatory control of androgen
signaling through androgen receptors (AR) (Evans, 1988; Ohuchi
et al., 1994; Yamanishi et al., 1995; Gnanapragasam et al., 2002;
Tanaka et al., 2002). Specifically, androgen-treatment induced,
whereas the androgen antagonist, bicalutamide, inhibited FGF8
protein, and mRNA expression in AR-positive mouse mammary
Shionogi carcinoma (SC)-3 cells (Tanaka et al., 1992; Yamanishi
et al., 1995). Similarly, androgen signaling increased Fgf8
mRNA expression in AR positive human prostate LNCaP cells
(Yamanishi et al., 1995; Gnanapragasam et al., 2002). These
data indicate that androgen signaling may be a general cellular
mechanism that induces Fgf8 expression levels.
In these studies, we tested whether androgen is able to induce
Fgf8 transcription in GnRH neurons. For this purpose, we
used the GnRH-secreting GT1-7 immortalized mouse cell line,
a model system that has been extensively used in the past to
study GnRH neuron biology (Mellon et al., 1990; Wetsel, 1995;
Wierman et al., 1995). More importantly, GT1-7 hypothalamic
neurons are responsive to androgen signaling because they
express classical nuclear ARs (Belsham et al., 1998; Brayman et al.,
2012a,b). In addition, we showed that GT1-7 neurons express
significant levels of Fgf8 mRNA, while our previous studies
showed that GT1-7 neurons express Fgfr1 and Fgfr3 mRNA
(Mott et al., 2010). These cellular traits made GT1-7 neurons
a suitable model system to study how androgen regulates Fgf8
transcription at the molecular level in GnRH secreting cells.
We first examined two questions: (1) Does AR interact with
the 5′UTR promoter region of the mouse Fgf8 gene in GT1-7
neurons and (2) Does androgen modulate Fgf8 mRNA levels in
GT1-7 neurons and in embryonic mouse OP cells? In addition,
because the Fgf8 gene is enriched for CpG islands, we asked
whether changes in DNA methylation affect Fgf8 mRNA levels
in GT1-7 neurons.
Here we will discuss our data demonstrating that while
AR interacts with the Fgf8 promoter region, this interaction
was androgen-independent, and that androgen-treatment did
not affect Fgf8 mRNA levels. In contrast, inhibition of
DNA methyltransferases (DNMT) significantly upregulated Fgf8
mRNA levels.
MATERIALS AND METHODS
Timed-Breeding of Mice
Adult 129P2/OlaHsd*CD-1 male × female mice were timed-
bred in the late afternoon in our animal facility (12L:12D cycle)
with access to food and water ad libitum. All procedures were
approved by the Institutional Animal Care and Use Committee
at Kent State University. In the morning, females with a sperm
plug were denoted as embryonic day (E) 0.5.
Androgen Response Elements in the 5′UTR
Region of Fgf8
Identification and prediction of transcription factor consensus
sites were determined through MatInspector (Genomatix
Software GmbH, Munich, Germany), which indicated the
presence of three androgen response element (ARE) sites with
a matrix similarity of greater than 0.88 (1 indicating a perfect
match) within the 5000 bp 5′ promoter region upstream from the
translational start site (Figure 1). The 5000 bp 5′UTR of Fgf8 was
selected due to it’s close proximity to the first coding exon in the
Fgf8 gene and the presence of a large CpG island, which is well
correlated to promoter regions (Calo andWysocka, 2013). Given
that the 5′UTR has no TATA box, the transcriptional start site(s)
are currently unknown (Gemel et al., 1999). Previous literature
has also indicated that the human Fgf8 5′UTR promoter region
lies within this 5 Kb stretch (Gnanapragasam et al., 2002).
GT1-7 Neurons
Immortalized mouse GnRH neurons (GT1-7) (Generously
donated by Dr. Pamela Mellon, University of San Diego, CA)
were grown in phenol-red free DMEM containing 4.5 g/L
pyruvate and 548mg/L-glutamine, 10% fetal bovine serum
(ATCC, Manassas, Virginia), 1% pen/strep (Gemini Bio–
Products, Sacremento, California), and 25µg/ml Plasmocin
(InvivoGen, San Diego, California; Mellon et al., 1990). Cells
were kept in an humidified incubator at 37◦C with 5% CO2.
For our experiments, GT1-7 neurons were grown to 70–80%
confluency, washed three times in a phosphate buffer solution,
and cultured for 16 h in DMEM containing 10% dextran-charcoal
stripped fetal bovine serum prior to pharmacological treatments
(see below).
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FIGURE 1 | (A) Immunocytochemistry of GnRH expressing GT1-7 neurons (gray) and (B) negative control (no primary antibody). Scale bar = 25µm. (C) PCR in
GT1-7 neurons. lane 1, no cDNA; lane 2, AR; lane 3, Fgf8; lane, FgfR1; lane 5, GnRH. (D) Analysis of the mouse Fgf8 5′-UTR region [5 Kb upstream of the translation
start site (+1)] with Matinspector (Genomatix) revealed the presence of three ARE sites upstream of the translation start site with a shared consensus sequence.
Relative position of F (forward) and R (reverse) flanking primer pairs (1, 2, 3) used to detect ARE 1 (−3077/−3058), ARE 2 (−1941/−1922), and ARE 3 (−528/−509).
Immunohistochemistry in GT1-7 Neurons
GT1-7 neurons were fixed with fresh ice-cold 4%
paraformaldehyde for 30min. Following, cells were washed
in TBS (3 × 5min) on a 2D rotator, incubated in primary
rabbit polyclonal anti-GnRH (1:5000, generously donated
by Dr. Pei-San Tsai, University of Colorado Boulder,
CO) made in TBS/0.3% Triton-X (Fisher Scientific,
Pittsburgh, PA) and 2% normal goat serum for 2 days
at 4◦C. Cells were washed with TBS and incubated with
biotinylated-goat anti-rabbit (1:600) for 2 h at room
temperature followed by ABC (1:800) (Vector Laboratories,
Burlingame, CA) in TBS for 2 h at room temperature,
and reacted with 0.05% diaminobenzidine (Sigma-Aldrich,
St. Louis, MO) containing 0.01% H2O2 in TBS for
20min.
AR Chromatin Immunoprecipitation in
GT1-7 Neurons
Chromatin immunoprecipitation (ChIP) was used to examine
whether AR interacted with the 5′UTR promoter region of the
mouse Fgf8 gene in GT1-7 neurons in the presence or absence
of dihydrotestosterone (DHT). GT1-7 cells were treated with
vehicle (0.005% ethanol) or 100 nM DHT for 4 h. Following,
GT1-7 neurons were processed for EZ-Magna-ChIP assays
(Millipore, Billerica, MA, USA) according to manufacturer’s
instructions. Briefly, cells were cross-linked with 1% formalin
for 15min and lysed. The protein cross-linked genomic DNA
was fragmented to 200–600 base pairs through sonication.
Following, the fragments were immunoprecipitated using 1µg
of either rabbit polyclonal antibody against AR (Millipore,
Billerica, MA, USA) or control IgG (Millipore, Billerica, MA,
USA) for 2 h at 4◦C, which was pulled down using agarose-A
beads coupled to magnets. Proteinase K (10mg/ml) was used
to reverse crosslinking, and DNA was isolated. The relative
amount of AR occupancy on the identified ARE sites in the
5′UTR region of Fgf8 was measured using using a Mastercycler
EP Realplex2 (Eppendorf, Hauppauge, NY) with SYBR Green
PCR Master Mix (Roche, Basel, Switzerland). For this purpose,
three primer sets were designed to flank the identified ARE
1, ARE 2, and ARE 3 sequences (Table 1). ChIP signal was
normalized to background by using a 1% input, adjusted to
100%. Non-specific primers flanking upstream of the 5′UTR
region of Fgf8 were used as negative controls for each pull-
down. All results were performed in at least three independent
experiments.
Quantification of Fgf8 and Fgfr1 mRNA
Levels in DHT-Treated GT1-7 Neurons
GT1-7 cells were treated with vehicle (0.005% ethanol) or
100 nM DHT for 2, 4, or 48 h. This DHT concentration is
a saturating amount given that the equilibrium dissociation
constant (Kd) of AR is ∼2 nM (Wilson and French, 1976),
and was used in previous studies investigating androgen
signaling in GT1-7 neurons (Belsham et al., 1998). Additionally,
transfection of human AR-GFP plasmid into GT1-7 cells in
the presence of 100 nM DHT was sufficient to translocate AR
into the nucleus (unpublished data). Total cellular RNA was
extracted with TriPure (Roche, Indianapolis, IN) according to
the manufactures instructions. RNA purity and concentration
was measured using the Synergy H2 multi-mode reader with a
Take3 Micro-Volume plate adapter (Biotek, VT). ProtoScript R©
II First Strand cDNA Synthesis Kit (New England Biolabs, MA)
was used to reverse transcribe 1µg of total RNA according
to the manufacturers instructions. RT-qPCR was performed
in triplicate with gene-specific primers (Table 1) using a
Mastercycler EP Realplex2 (Eppendorf, Hauppauge, NY) with
SYBR Green PCR Master Mix (Roche, Basel, Switzerland).
Relative Fgf8 and Fgfr1 mRNA expression levels were calculated
using the 11−2CT method (Livak and Schmittgen, 2001).
Hypoxanthine phosphoribosyltransferase 1 (Hprt-1) was used as
a housekeeping gene.
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TABLE 1 | Primer sequences used for detecting Fgf8, Fgfr 1, GnRH and AR mRNA expression, and ARE containing DNA sequences within the Fgf8
promoter region.
Gene Forward (5′-3′) Reverse (5′-3′) bp
Fgf8 AGAAGACGGAGACCCCTTCG TGAATACGCAGTCCTTGCCTT 142
Fgfrl ATGGTTGACCGTTCTGGAAG TGGCTATGGAAGTCGCTCTT 171
GnRH GGCATTCTACTGCTGACTGTGT CTACATCTTCTTCTGCCTGGCT 252
AR GGACAGTACCAGGGACCAT CCAAGTTTCTTCAGCTTACGA 288
ARE 1 CTCCACTGATCGCCCATTGT GCAAATCTCTGCAACTGCGT 396
ARE 2 AGTCATTCTAAAGGCCCCTCA GACGGACTCCAGTGTCCAAG 83
ARE 3 ACCCGACCCTAAGCAGATCA TACCCTTGCCTGTCTCTTCCA 132
Non-Specific Fgf8 GTCAGTCTGCGAATATAGCTCAG CACAGTACCAACAAGTGTCACAG 314
Quantification Fgf8 and GnRH mRNA
Levels in E10.5 Nasal Explants Treated with
DHT
Adult pregnant wildtype female 129P2/OlaHsd*CD-1 mice were
sacrificed at E10.5. The uterine horns were quickly removed form
the mice and kept in sterile ice-cold phosphate-buffered saline
(Sigma-Aldrich, MO). Following, the nasal region containing
the OP was surgically isolated using a dissection macroscope,
placed on 0.85µm Durapore membrane filters (Millipore,
Darmstadt, Germany), transferred to cell tissue culture inserts
(Greiner Bio-One, Kremsmünster, Austria), and grown using the
liquid-air interphase method with in phenol-red free Dulbecco’s
modified Eagle’s medium (DMEM)/F12/glutamax (Thermofisher
Scientific, MA) supplemented with B27 (Thermofisher Scientific,
MA) and 1% pen/strep/myc (Sigma-Aldrich, MO) media.
E10.5 nasal explant tissues were collected, immediately flash
frozen and kept at −80◦C, and used as 0 days in vitro
(DIV) samples or grown in culture for 3DIV with media
containing vehicle (0.005% ethanol) or 100 nM DHT.
Afterwards, total RNA was isolated from all explants (i.e.,
0 and 3DIV). Relative Fgf8, Fgfr1, GnRH, and AR mRNA
expression levels were measured and calculated as described
above.
Quantification Fgf8 and GnRH mRNA
Levels in DNA Methyltransferase
Inhibitor-Treated GT1-7 Neurons
First, GT1-7 neurons were treated with vehicle (0.005% DMSO)
or 1µM 5-azacitidine (AZA) for 72 h. Our AZA dose and length
of treatment was based on previous studies showing that these
conditions were able to induce gene expression (Xin et al., 2015;
Zhou and Hu, 2015). These studies were followed-up in second
experiment where GT1-7 neurons were treated with AZA for 72 h
in the presence or absence of 100 nM DHT for 4 h. Total cellular
RNA extraction and cDNA synthesis were performed (see above).
Relative Fgf8 and GnRH mRNA expression levels were measured
and calculated as described above.
Statistical Analysis
Data were analyzed using Student t-tests or one-way analysis
of variance (ANOVA) with treatment and/or DIV as between
subject variables. Holm-Sidak tests were used for post hoc
analysis. Group n’s are given in the figure legends. Differences
were considered significant if p < 0.05.
RESULTS
The Mouse Fgf8 5′UTR Regions Harbors 3
Are Consensus Sites
Sequence analysis revealed three ARE sequences from
the translation start site (+1): 5′-actaaacatgttGTCCcag-3′
(ARE 1: -3077 bp), 5′-tgctttctctgtGTGCttg-3′ (ARE 2: -
1941 bp), and 5′-agctgccgtcctGTCCttc-3’ (ARE 3: -528 bp)
(Figure 1D).
GnRH, AR, Fgfr1, and Fgf8 mRNA
Expression in GT1-7 Neurons
In these parametric studies, we established that our GT1-7
neurons were neurochemically similar to those used in other
laboratories (Mellon et al., 1990; Belsham et al., 1998; Mott et al.,
2010; Brayman et al., 2012b). First, using ICC, we confirmed
the presence of GnRH peptide in these cells (Figures 1A,B)
Next, using PCR, we verified that our GT1-7 neurons express
significant levels of GnRH, AR, and Fgfr1 and Fgf8 mRNA
(Figure 1C).
AR Interacts with the 5′UTR Region of Fgf8
in GT1-7 Neurons
We then asked whether ARs are associated with the 5′UTR region
of Fgf8 in GT1-7 neurons. First, Student t-tests showed that ChIP
with an AR-specific antibody was able to pull-down more 5′UTR
Fgf8 DNA sequences that contain ARE 1, ARE 2, and ARE 3, in
contrast to control IgG (p < 0.05; Figures 2A–C). In addition,
Student t-tests showed that AR interacted with the AREs in a
ligand-independent fashion indicating that DHT was unable to
affect this interaction (Figures 2D–F).
DHT Did Not Affect Fgf8 mRNA Levels in
GT1-7 Neurons
Previous studies showed that androgen was able to induce the
mRNA expression levels of Fgf8 inmouse SC-3 breast and human
LNCaP prostate cancer cells (Gnanapragasam et al., 2002; Tanaka
et al., 2002). In order to study, whether that was also the case
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FIGURE 2 | ChIP gel electrophoresis in vehicle (VEH; n = 3) or DHT (n = 3) treated GT1-7 neurons (A–C) and qRT-PCR analysis of ARE 1-3 sites (D–F).
Using an AR-specific antibody, we found that AR interacts with the ARE 1-3 sites as compared to non-specific IgG immunoprecipitation (*p < 0.05). However,
DHT-treatment did not enhance AR binding to ARE 1–3 sites.
in GnRH-secreting neurons, we treated GT1-7 neurons with
100 nM DHT for 2, 4, or 48 h. Our results showed that neither
Fgf8 (Figures 3A–C) nor Fgfr1 (Figures 3D–F) mRNA levels
were affected by DHT when compared to vehicle-treated GT1-7
neurons.
DHT Did Not Affect Fgf8 mRNA Levels in
Nasal Explants
The inability of DHT to modulate Fgf8 mRNA expression
in GT1-7 neurons may have been due to their immortalized
status. Therefore, we used E10.5 nasal explants to investigate
whether 3DIV DHT treatment would be able to increase or
decrease Fgf8, Fgfr1, AR, or GnRH mRNA expression in an
organotypic model system. Student t-tests showed that Fgf8
mRNA levels in 3DIV nasal explants did not differ between
vehicle-treated and DHT-treated 3DIV nasal explant tissue
(Figure 4A). Additional analysis showed that Fgf8 mRNA levels
were, however, significantly lower in 3DIV nasal explants as
compared to 0DIV nasal tissue (p < 0.05). Student t-
tests showed that Fgfr1 mRNA levels in 3DIV nasal explants
did not differ between vehicle-treated and DHT-treated 3DIV
nasal explants (Figure 4B), although Fgfr1 mRNA levels were
significantly higher in 3DIV nasal explants as compared to 0DIV
nasal tissue (p < 0.05). Student t-tests showed thatGnRHmRNA
levels in 3DIV nasal explants did not differ between vehicle-
treated andDHT-treated 3DIV nasal explants tissue (Figure 4C).
As expected, GnRH mRNA levels were significantly higher in
3DIV nasal explants compared to 0DIV nasal tissue (p < 0.001).
In contrast, Student t-tests showed that AR mRNA levels did
not differ between vehicle-treated and DHT-treated 3DIV nasal
explants (Figure 4D). On average AR mRNA levels seem to be
higher 0DIV nasal tissue compared to 3DIV nasal explants, but
however, did not reach significance.
Inhibition of DNA Methyltransferase
Upregulated Fgf8 mRNA Levels in Gt1-7
Neurons
Here, we asked whether changes in DNA methylation affect Fgf8
mRNA levels in GT1-7 neurons, because the Fgf8 gene structure
is enriched with CpG islands. In our first study, Student t-
tests showed that compared to vehicle treatment, AZA treatment
significantly increased Fgf8 (p < 0.05; Figure 5A) mRNA levels.
In contrast, AZA dramatically reduced GnRH mRNA levels
(p < 0.0001; Figure 5B). In our second study, one-way ANOVA
showed a significant treatment effect on Fgf8 mRNA levels
[F(3, 15) = 10.5, p < 0.005; Figure 5C]. Post hoc analysis showed
that AZA significantly increased Fgf8 mRNA levels compared to
vehicle (p < 0.01), DHT (p < 0.005), and AZA + DHT (p <
0.005) treatment groups. Interestingly, while we confirmed our
earlier results indicating that DHT does not affect Fgf8 mRNA
levels, we found that DHT prevented AZA-dependent increase
in Fgf8 mRNA levels. Moreover, one-way ANOVA revealed a
significant treatment effect on GnRH mRNA levels [F(3, 15) =
13.7, p < 0.005; Figure 5D]. Post hoc analysis showed that
compared to vehicle and DHT treatment groups, AZA treatment
significantly reduced GnRH mRNA levels (p < 0.05). Similarly,
compared to vehicle and DHT treatment groups, GnRH mRNA
levels were significantly lower in GT1-7 neurons treated with
AZA + DHT (p < 0.005). Moreover, compared to vehicle-
treatment, DHT treatment did not effect GnRH mRNA levels,
nor was DHT able to prevent AZA-dependent downregulation
of GnRH mRNA levels.
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FIGURE 3 | RT-qPCR for Fgf8 (A–C) and Fgfr1 (D–F) mRNA in GT1-7 neurons treated for 2 h with vehicle (n = 4) or 100nM DHT (n = 4), 4 h with vehicle
(n = 6), or 100nM DHT (n = 6), or 48h with vehicle (n = 3) or 100nM DHT (n = 3). DHT treatment did not signifigantly alter Fgf8 or Fgfr1 mRNA expression in
GT1-7 neurons.
DISCUSSION
Several novel discoveries are reported in this study. First,
we showed that AR interacts with 3 specific ARE sites
(ARE 1: -3077 bp; ARE 2: -1941 bp; ARE 3: -528 bp) in the
5′UTR region of the mouse Fgf8 gene in GT1-7 neurons.
Furthermore, we found that unliganded AR was already
recruited to all 3 ARE containing 5′UTR regions, which our
data found to be unaffected by the presence of DHT. Second,
in contrast to our hypothesis, which was based on previous
studies in SC3 and LNCaP cells, DHT did not modulate Fgf8
mRNA levels in GT1-7 neurons or nasal explants. In contrast,
inhibition of DNMT using AZA significantly upregulated Fgf8
mRNA levels, which concomitant DHT treatment prevented.
This suggests that although the 5′UTR region of the Fgf8 gene
allows for AR binding on three separate ARE consensus sites, the
function of androgen signaling may not be to upregulate Fgf8
transcription, but rather to moderate/inhibit the upregulatory
effects of other molecular processes, such as DNA methylation.
ChIP assays showed that AR interacts with the Fgf8 promoter,
which suggests that the ARE consensus sites found in the
5′UTR of Fgf8 are able to enlist ARs in GT1-7 neurons. These
results follow earlier studies reporting that ARs were closely
associated with the human Fgf8 promoter region LNCaP cells
(Gnanapragasam et al., 2002). However, to our surprise, our
DHT treatments did not increase AR recruitment to the mouse
Fgf8 promoter region. Contrarily, earlier findings in LNCaP
cells showed that the synthetic non-aromatizable androgen,
mibolerone was able to cause enhanced AR recruitment to
the human Fgf8 promoter region (Gnanapragasam et al.,
2002). Specifically, these earlier studies showed that mibolerone-
dependent AR recruitment occurred only at the most distal ARE
consensus site (out of 3 AREs) on the human Fgf8 promoter
region (Gnanapragasam et al., 2002). This discrepancy may be
due to technical differences in detection approaches. In our
studies, qPCR was used to quantify AR recruitment to the mouse
Fgf8 promoter, whereas AR recruitment to the human Fgf8
promoter in LNCaP cells was quantified after visualizing the
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FIGURE 4 | RT-qPCR for Fgf8, Fgfr1, GnRH, AR mRNA nasal explants treated for 3DIV with vehicle (n = 3) or 100nM DHT (n = 3 animals) (A–D). Inset
panels represent comparisons between 0DIV (n = 3) vs. collapsed 3DIV nasal explant expression data (n = 6), which showed that Fgf8 mRNA significantly decreased
(A), Fgfr1 mRNA signifigantly increased (B), GnRH mRNA signifigantly increased (C), and no significant difference in AR mRNA expression (D) after 3DIV. *p < 0.05.
PCR product on film. Alternatively, and more likely explanation
for these partially contradictory results may be due to inherent
biochemical differences between the androgenic agonists: DHT
is an endogenous and naturally occurring androgen, whereas
mibolerone is synthetic (Gnanapragasam et al., 2002). Indeed,
recent studies showed that although DHT and mibolerone are
non-aromatizable androgens, mibolerone may have distinct non-
physiological effects on the cell’s molecular signaling machinery,
such as that mibolerone can activate progestin receptors in
breast cancer cells, a non-physiological effect that DHT does
not exhibit (Cops et al., 2008). Similarly, the expression of
some miRNAs in LNCaP cells, such as miR-120 can be induced
in the presence of mibolerone, but not DHT (Segal et al.,
2015). Taken together, we hypothesize that AR recruitment to
the Fgf8 promoter under normal physiological conditions is
independent of the cellular and extracellular androgen milieu,
however a more extensive analysis of AR/ARE function are
needed to definitively rule out an androgen-mediated effect on
Fgf8 expression.
The lack of DHT-dependent induction of Fgf8mRNA in GT1-
7 neurons was unexpected, especially in light the data from
earlier studies in SC3 and LNCaP cells (Ohuchi et al., 1994;
Yamanishi et al., 1995; Gnanapragasam et al., 2002; Tanaka et al.,
2002). The ability of AR to drive transcription depends on the
recruitment of specific co-regulators, which may act directly
or indirectly with AR to modulate its ability to activate gene
transcription (Chung and Auger, 2013). It is well-known that
in addition to the presence of its cognate androgenic ligand,
the cellular complement of co-factors, such as SRC-1 and ARA-
70 plays a role in AR’s ability to drive transcription, and that
this complement is cell type dependent. Therefore, it is possible
that GT1-7 neurons do not have the pre-requisite complement
of co-factors that allows DHT to appropriately activate AR to
induce Fgf8 mRNA levels as it is the case in SC3 and LNCaP
cells.
Alternatively, regulation of Fgf8 transcription may be under
the control of DNA methylation status (Chung and Auger,
2013), an inference that is supported by our results. In
addition to harboring multiple CpG islands upstream and
downstream of the translation start site (http://www.ncbi.
nlm.nih.gov/epigenomics/), we found that AZA induced Fgf8
mRNA levels in GT1-7 neurons. Although, we currently
do not known whether AZA directly changed the DNA
methylation status of the Fgf8 promoter, our results follow
previous studies indicating that hypomethylation in primary
rhabdomyosarcoma tumors was correlated with higher Fgfr1
mRNA expression levels in (Goldstein et al., 2007). These
studies confirmed earlier experiments in which DHT treatment
for 4 h does not affect Fgf8 mRNA levels; however, to our
surprise, DHT did eliminate the AZA-dependent rise in Fgf8
mRNA levels. We speculate that in contrast to our original
hypothesis, androgen signalingmay act to act downregulate DNA
methylation-dependent upregulation of Fgf8 mRNA expression,
and hence limit the morphogenetic or proliferative effects of
FGF8 signaling (Ornitz and Itoh, 2015). Nonetheless, these
results indicate that changes in DNA methylation status can
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FIGURE 5 | RT-qPCR for Fgf8 and GnRH mRNA in GT1-7 neurons treated with vehicle (n = 4) or 1µM AZA (n = 4) for 72h. AZA-treatment significantly
increased Fgf8 mRNA expression (p < 0.05) (A) and reduced GnRH mRNA levels (p < 0.0001) (B). RT-qPCR for Fgf8 and GnRH mRNA expression in GT1-7 neurons
treated with vehicle or AZA for 3 days and vehicle or 100 nM DHT for 4 h (C,D). One-way ANOVA showed a significant treatment effect on Fgf8 mRNA levels
[F(3, 15) = 10.5, p < 0.005] (C). Post hoc analysis showed that AZA increased Fgf8 mRNA levels compared to vehicle (n = 4; p < 0.01), DHT (n = 4; p < 0.005) and
AZA + DHT (n = 4; p < 0.005) treatment groups. One-way ANOVA showed a significant treatment effect on GnRH mRNA levels [F(3, 15) = 13.7, p < 0.005] (D). Post
hoc analysis showed that compared to vehicle and DHT treatment groups, AZA treatment significantly reduced GnRH mRNA levels (n = 4; p < 0.05). GnRH mRNA
levels were significantly lower in GT1-7 neurons treated with AZA + DHT (n = 4; p < 0.005). DHT treatment did not effect GnRH mRNA levels, nor was DHT able to
prevent AZA-dependent downregulation of GnRH mRNA levels. * or different letter indicate p < 0.05.
induce Fgf8 transcription, and that androgen signaling is
functional.
In contrast, AZA caused a dramatic decrease in GnRH
mRNA levels in GT1-7 neurons. This result was unexpected,
because evidence from earlier studies in Rhesus monkey nasal
explants showed that demethylation of the GnRH promoter
correlates with a rise in GnRH mRNA levels (Kurian et al.,
2010). This discrepancy may be due to the inherent differences
between our experimental model systems. Alternatively, and
more likely, the decrease in GnRH mRNA levels may be related
to the increase in Fgf8 mRNA expression. Indeed, previous
studies showed that treatment with recombinant FGF8b protein
not only reduced GnRH promoter activity, but also GnRH
mRNA levels in GT1-7 neurons (Mott et al., 2010). Currently,
we are studying whether FGF8 signaling overrode the rise of
GnRH mRNA levels due to the DNA demethylating effects
of AZA.
In conclusion, our data showed that while AR interacts
with the Fgf8 promoter region, this interaction was androgen-
independent, and that androgen treatment alone did not affect
Fgf8 mRNA levels, indicating that androgen signaling does not
induce Fgf8 transcription in GT1-7 GnRH-secreting neurons
or nasal explant cells. In contrast, our studies did show that
inhibition of DNA methyltransferases significantly upregulated
Fgf8 mRNA levels indicating that Fgf8 transcriptional activity
may be dependent on methylation status.
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